Skip to content
ppharmaranks
Menu
Class IIOngoing

Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) recall

FDA recall D-0596-2025 · initiated Aug 20, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Sep 3, 2025How we research

Baxter Healthcare Corporation recalled Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) in Aug 2025 — an FDA Class II recall (D-0596-2025) because Discoloration.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Discoloration

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 24A27G66, Exp 12/31/2025

Quantity recalled: 13,000 containers

Details

Product
Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60.
Recalling company
Baxter Healthcare Corporation
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S.A. Nationwide
Initiated
Aug 20, 2025
FDA report date
Sep 3, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) recalled?
Baxter Healthcare Corporation recalled Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) in Aug 2025 — an FDA Class II recall (D-0596-2025) because Discoloration. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) recalled?
Per the FDA enforcement record, the reason for recall D-0596-2025 was: Discoloration
Is a recalled Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Acetaminophen Injection 1000 mg/100 mL (10 mg/mL) are affected?
Distributed: U.S.A. Nationwide. The recall covers these lots — Lot #: 24A27G66, Exp 12/31/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0596-2025.

Source: openFDA Drug Enforcement record D-0596-2025

← All drug recalls